Li Juan

20PUBLICATIONS
21CO-AUTHORS
Medical virologyMedical mycologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 12, 2026
Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

|May 27, 2026
Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

|May 10, 2026
Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

|Nov 03, 2025
Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Xiaozhe Li, Meilan Chen, Junru Liu

|Aug 01, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.

Yun Wang, Shuzhao Chen, Zhijian Liang

|Jan 25, 2025
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram.

Yanjuan Li, Lifen Kuang, Beihui Huang

Pageof 4

Frequent Collaborators

4 joint publications

Junru Liu

2 joint publications

Yuan Jian

2 joint publications

Juan Du

2 joint publications

Zhiyao Zhang